$4.46
+ $0.25 (5.94%)
End-of-day quote: 02/17/2024
NasdaqCM:AVTX

Avalo Therapeutics Stock Price

0
Underperform
1
2
3
4
5
6
7
8
9
10
1M 3M YTD 1Y 2Y 5Y 10Y 20Y
P/E Ratio
0.0
Market Cap
0.01B
Price-to-book Ratio
0.24
Earnings
-
Dividend
$0.00
Div Yld
0.00%
Dividend Growth
0 Years
Beta
1.00
Short Interest
7.99%
Forecast 1Y
0.00%
Analyst Price Target
$0.00
LTG 5Y
0.00%
52 week range
$3.95 - $1227.76